Chennai Meenakshi Multispeciality Hospital Governance Update

MD Re-appointment approved for 3-year term; CEO consultancy fees set at Rs 96 Lakhs per annum.

Reader Takeaway: Re-designation of independent directors and MD approval via special resolution are key watchpoints for investors.

What just happened

Chennai Meenakshi Multispeciality Hospital held a board meeting on September 1, 2026, resulting in multiple governance changes. The board re-designated Mr. A. F. Simeon Telfer and Ms. Sindu Chawla from Non-Executive Independent Directors to Non-Executive Non-Independent Directors. Consequently, the company has reconstituted its Audit, Nomination and Remuneration, and Stakeholders' Relationship committees.

Managing Director Re-appointment

The board approved the re-appointment of Mrs. R. Gomathi as Managing Director and Chairman for three years, beginning November 11, 2026. Because Mrs. Gomathi is 70 years old, the company requires a special resolution at the upcoming 36th Annual General Meeting (AGM) to finalize this appointment. Her remuneration is set at Rs 1,00,000 per month.

CEO Professional Fees

Dr. Thanigai Vendan Moorthy, the company’s CEO and Key Managerial Personnel, will receive a professional fee structure for clinical and surgical services for FY 2026-27. This includes a fixed fee of up to Rs 3,00,000 per month and a variable surgical fee of up to Rs 5,00,000 per month, totaling a maximum of Rs 96,00,000 annually. The company states these fees are distinct from his executive salary and are conducted on an arm's length basis.

36th AGM Details

The company will hold its 36th AGM on September 30, 2026, at 11:00 AM via video conferencing. Book closure for the AGM is scheduled from September 24 to September 30, 2026.

What to track next

Shareholders should monitor the AGM proceedings, specifically the vote on the special resolution for the MD’s re-appointment, as this will determine the leadership continuity for the next three-year term.